Enrollment Completed in C-BEYOND Phase 3 Trial with More Than 880 HCV Treatment-Naïve Patients in US and Canada C-BEYOND Topline Results Expected Mid-2026 C-FORWARD Phase 3 Trial, Conducted Outside ...
A lifestyle intervention was associated with significant reductions in BMI, urine albumin-to-creatinine ratio and eGFR for ...
Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...
A recent study reveals promising results for CLL patients using zanubrutinib and venetoclax, highlighting effective ...
A German multicentre study reveals strong patient demand for systemic therapy in atopic dermatitis and psoriasis. Learn more about treatment preferences and drivers.
SAN DIEGO – New research suggests more than one in five “opioid-naïve” patients continue to use the pain medication three months after having a procedure, underscoring the often-overlooked role ...
Treatment-naive patients show greater BMD gains taking romosozumab than do patients who had previous antiresorptive treatments. "We conclude that prior antiresorptive therapy, particularly the ...
The effect of dupilumab was investigated among patients with severe and uncontrolled chronic rhinosinusitis with nasal polyps (CRSwNP). Among patients who did or did not undergo surgery to treat their ...
We present results of an analysis of IBM MarketScan databases that evaluates treatment patterns and health care costs for treatment-naïve patients with psoriatic arthritis. Objectives: Pharmacologic ...
A drug-drug interaction (DDI) study to assess the effect of oral galeterone on the pharmacokinetics (PK) of oral midazolam. This is an ASCO Meeting Abstract from the 2016 Genitourinary Cancers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results